Received May 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | ER8735 | — |
Surgery to remove cancerous kidney; couldn't walk at all; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 75-year-old female patient received BNT162b2 (BNT162B2), on 04May2021 as dose 2, single (Lot number: ER8735) at the age of 75 years for covid-19 immunisation. The patient's relevant medical history included: "colon cancer", start date: 2009 (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot: EW0150), administration date: 12Apr2021, when the patient was 75-year-old, for Covid-19 immunization. The following information was reported: RENAL CANCER (medically significant) with onset 2021, outcome "unknown", described as "Surgery to remove cancerous kidney"; GAIT INABILITY (non-serious) with onset 2021, outcome "unknown", described as "couldn't walk at all". Therapeutic measures were taken as a result of renal cancer. Clinical course: In Sep2021, patient was walking 40 minutes each day. In Sep2021, Surgery to remove cancerous kidney after which she couldn't walk at all. Oct2021 to Sep2022 gradually increased walking from zero to 20 minutes per day.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500052642 Same patient, different dose and event;
Medical History/Concurrent Conditions: Colon cancer